Papers
1
Total Citations
36
H-Index
1
About
Dr. Susan Ou has made pioneering contributions to epigenomics and high-throughput genomic technologies, particularly through her work on chromatin immunoprecipitation (ChIP) methodologies. Her research focuses on developing automated, scalable platforms for mapping protein-DNA interactions, which are critical for understanding gene regulation, transcription factor binding, and histone modifications. Dr. Ou’s most cited study, "Fully automated high-throughput chromatin immunoprecipitation for ChIP-seq: Identifying ChIP-quality p300 monoclonal antibodies" (2014, 36 citations), introduced a breakthrough robotic system that dramatically increased the reproducibility and throughput of ChIP-seq experiments. This work not only enabled the systematic validation of p300 antibodies—a key cofactor in enhancer biology—but also set a new standard for large-scale epigenomic profiling. Her contributions have been instrumental in advancing consortium-driven projects, such as the ENCODE and Roadmap Epigenomics initiatives, by providing robust tools for genome-wide mapping of regulatory elements. Dr. Ou’s innovations have empowered researchers to explore chromatin dynamics with unprecedented efficiency, making her a vital figure in the transition from manual, low-throughput assays to fully automated, high-fidelity genomic analyses.
Research Focus
Key Achievements
Top Papers
- 1